Cautions over idiopathic aldosteronism

[1]  N. Kaplan.  Cautions over the current epidemic of primary aldosteronism , 2001, The Lancet.

[2]  W. Young,et al.  A review of the medical treatment of primary aldosteronism , 2001, Journal of hypertension.

[3]  M. Stowasser.  Primary aldosteronism: revival of a syndrome. , 2001, Journal of hypertension.

[4]  W. Young,et al.  Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. , 2000, The Journal of clinical endocrinology and metabolism.

[5]  M. Omura,et al.  Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  C. Gomez-Sanchez,et al.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  R. Jung,et al.  High prevalence of primary aldosteronism in the Tayside hypertension clinic population , 2000, Journal of Human Hypertension.

[8]  F. Veglio,et al.  CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. , 2000, Hypertension.

[9]  G. Uwaifo,et al.  Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism , 2000, Journal of Human Hypertension.

[10]  I. Miyamori,et al.  Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. , 1999, The Journal of clinical endocrinology and metabolism.

[11]  A. Semplicini,et al.  Screening for primary aldosteronism with a logistic multivariate discriminant analysis * , 1998, Clinical endocrinology.

[12]  D. Mcareavey,et al.  Similarity of idiopathic aldosteronism and essential hypertension. A statistical comparison. , 1983, Hypertension.

[13]  J. Brown,et al.  Low-renin ("primary") hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome. , 1978, American heart journal.